Web Results

Gilead (GILD) Stock Likely to Beat This Earnings Season - July 21 ...

www.zacks.com/stock/news/224485/gilead-gild-stock-likely-to-beat-this-earnings-season

Jul 21, 2016 ... Gilead Sciences (GILD), which is set to report second-quarter 2016 ... In the first quarter of 2016, Gilead's hepatitis C virus (HCV) franchise, consisting of blockbuster drugs ... On the second-quarter call, investors should keep an eye on the ... Here are a couple of other health care stocks that you may want to ...

Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in ...

www.nasdaq.com/article/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-in-immuno-oncology-deal-cm587513

Mar 2, 2016 ... The fourth quarter earnings season is winding down, with quite a ... Tesla's New P100D: Everything You Need to Know ... Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in ... Gilead is quite focused on bringing new HIV treatments to market and to boost sales of its blockbuster HIV franchise.

Biotech Stock Roundup: Gilead Gets FDA Nod for ... - NASDAQ.com

www.nasdaq.com/article/biotech-stock-roundup-gilead-gets-fda-nod-for-hcv-drug-regulus-hit-by-clinical-hold-cm642890

Jun 29, 2016 ... Analyst Activity; Upgrades/Downgrades · Forecast Changes · Earning Surprises ... Tesla's New P100D: Everything You Need to Know ... Meanwhile, Gilead continues to expand its blockbuster HCV franchise. ... for the duvelisib program, and will focus on submitting a NDA in the fourth quarter of 2016. 3.

The Zacks Analyst Blog Highlights: Gilead, Regeneron, Medivation ...

finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-133001398.html

Apr 7, 2016 ... Biotech Stock Roundup ... Descovy, which is considered to have blockbuster potential, is the third ... Plans are on to submit regulatory applications in the third quarter of the year. ... What you need to know on Wall Street right now ... Best Buy jumps on earnings; Square gets an upgrade; Toll Brothers revenue ...

TheStreet: Stock Market - Business News, Market Data, Stock Analysis

www.thestreet.com/

4:53 PM Zooming in on Instagram — Tech Roundup ... FDIC: Bank Income Rose in Second Quarter Driven by Loan Growth, Trading ... 5 Things You Must Know Before the Market Opens Wednesday ... Hedge Funds Love These 5 Stocks -- but Should You? ... Gilead Sinking Stock Price Calls Out for New Rescue Plan ...

The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene ...

finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-133001530.html

May 5, 2016 ... Biotech Stock Roundup. Earnings were the key focus this week with several major biotech ... According to AbbVie, the candidate has blockbuster potential and could ... The company plans to speed up its efforts to bring new treatments ... investors know what stocks to buy and which to sell for the long-term.

GILD - Gilead Sciences, Inc. | Crowdsourced Stock Ratings - Vetr

www.vetr.com/research/NASDAQ:GILD

The most recent quarterly report saw Gilead's (NASDAQ: GILD) earnings drop ..... Everything You Need To Know About Biotech Right Now (Podcast With Bret Jensen) ... Stocks to Watch Evening Roundup: Disney's Earnings, US Steel's Stock Sale, ... Which begs the question: Has a blockbuster drug ever been more of an ...

Drug Channels: October 2014

www.drugchannels.net/2014_10_01_archive.html

Oct 1, 2014 ... News Roundup, October 2014: Walgreens, Cardinal Health, ... Yesterday, Gilead Sciences reported another blockbuster quarter for Sovaldi sales. ... Based on the chart below, I think you'll agree that Sovaldi is the most legendary of them all. ... should—but probably won't—mute critics of preferred networks.

3 Things to Watch With Gilead Sciences - The Motley Fool

www.fool.com/investing/general/2012/07/09/3-things-to-watch-with-gilead-sciences.aspx

Jul 9, 2012 ... These factors could hold the key to big gains with Gilead Sciences. ... $1.84 billion of Gilead's $2.21 billion in net product sales in the first-quarter. ... Just in case you weren't aware, the race to create the next blockbuster ... Foolish roundup. Now that you know what to watch for, it should be easier to an...

Stock Quote ABBV AbbVie Inc. - Finviz

finviz.com/quote.ashx?t=ABBV

10:04AM, AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster ... 06: 30AM, Analysts: Gilead Should Divide Itself and Conquer. Aug-11-16 05:30PM, Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat ... 08:40AM, 5 Things You Must Know Before the Market Opens Friday.

More Info

Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings - April 26 ...

www.zacks.com

Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on Apr ... Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should continue to ... Here are a couple of other health care stocks that you may want to consider ... Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review.

Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV ...

finance.yahoo.com

Jul 27, 2016 ... With the second quarter earnings season in full swing, several ... Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure ... of the label of its blockbuster drug, Revlimid, as maintenance treatment in a .... Here's why you need to update your iPhone now, and how to do it.

Biotech Stock Roundup: Gilead Gets FDA Nod for ... - Yahoo Finance

finance.yahoo.com

Jun 29, 2016 ... Meanwhile, Gilead continues to expand its blockbuster HCV franchise. ... duvelisib program, and will focus on submitting a NDA in the fourth quarter of 2016. ... Today, you can download 7 Best Stocks for the Next 30 Days. .... to under-estimate the incremental earnings contribution that Schlumberger should ...